Eupraxia Pharmaceuticals Inc. is trading 8.5% up at $6.54 in pre-market, extending its rebound after closing at $6.29 on June 17, 2026.

  • The move appears to be a continuation of short-term momentum following a recent technical pullback and bounce.
  • There are no fresh company-specific headlines or regulatory filings to account for the current price action.
  • The gains come amid a stronger, risk-on broader market backdrop supporting the pharmaceutical sector.